BioNTech is a German biotechnology company known for its work in developing and manufacturing immunotherapies and vaccines, particularly in the field of cancer treatment and infectious diseases. It gained significant prominence for its collaboration with Pfizer in creating one of the first COVID-19 vaccines approved for emergency use, utilizing messenger RNA (mRNA) technology. Founded in 2008, BioNTech focuses on personalized medicine and has a portfolio that includes various therapeutic and preventive vaccines in clinical development. The company’s innovative approach aims to harness the body’s immune system to combat diseases more effectively.
Успіх вакцини BioNTech на основі мРНК переходить до нового етапу зосередження на терапіях раку. Компанія повідомила про зниження прибутку на акцію до 1.08 євро, але перевершила очікування ринку. Дохід зменшився…